Elsevier

Medical Hypotheses

Volume 36, Issue 3, November 1991, Pages 190-194
Medical Hypotheses

Protocol for the use of vitamin C in the treatment of cancer

https://doi.org/10.1016/0306-9877(91)90128-LGet rights and content

Abstract

A protocol for the use of vitamin C in the treatment of cancer, developed over a number of years in Vale of Leven Hospital, Scotland, is presented. Clinical experience has shown this protocol to be both safe and efficient. It need not be followed ‘to the letter’, but provides general guidance to physicians unfamiliar with this therapeutic approach. It recommends that all cancer patients treated in this fashion be given an initial course of intravenous ascorbate followed by a maintenance oral dose to be continued indefinitely thereafter. The importance of continuous as opposed to intermittent administration is emphasized.

References (38)

  • D Rather

    CBS Network News

    (January 20, 1985)
  • E Cameron et al.

    Ascorbic acid and cancer: a review

    Cancer Res

    (1979)
  • E Cameron et al.
  • RH Yonemoto et al.

    Enhanced lymphocyte blastogenesis by oral ascorbic acid

  • R Anderson

    Ascorbic acid and immune functions: mechanisms of immunostimulation

  • RS Panush et al.

    Modulation of certain immunologic responses by vitamin C. III. Potentiation in vitro and in vivo lymphocyte responses

    Int J Vitam Nutr Res

    (1982)
  • BV Siegel et al.

    Vitamin C and the immune response

    Experimentia

    (1977)
  • BV Siegel et al.

    The multifactorial role of vitamin C in health and disease

    Int J Vitam Nutr Res

    (1982)
  • L Benade et al.

    Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1, 2, 4-triazole

    Oncology

    (1969)
  • Cited by (23)

    • Ascorbate kills breast cancer cells by rewiring metabolism via redox imbalance and energy crisis

      2021, Free Radical Biology and Medicine
      Citation Excerpt :

      A later clinical trial conducted by the Mayo clinic rebutted the findings, triggering a heated debate on the issue [14]. Notably, the latter study used the oral route for ascorbate administration, while those of Cameron and Pauling resorted to intravenous injection [15]. Oral supplementation is subject to absorption limitations [16] and therefore yields a maximum plasma concentration of about 0.22 mM [17], while 100-time higher plasma concentrations could be safely achieved intravenously [16,18,19].

    • The Antioxidant Debate

      2010, Explore: The Journal of Science and Healing
      Citation Excerpt :

      Vitamin C was postulated to have an important role in the treatment of cancer based upon the observations that vitamin C is involved in host resistance to cancer and that patients with cancer are often found to be depleted of vitamin C. Supplementation with vitamin C was suggested for its potential role to increase host resistance to cancer by stimulating immune function, increasing resistance to intercellular ground substance hydrolysis by hyaluronidase elaborated by tumor cells, stabilizing the production of hormones, and by protecting the pituitary-adrenal axis from the effects of stress.41,42 Case studies of terminal-stage cancer patients treated with a combination of high-dose oral and intravenous vitamin C who demonstrated prolonged survival were reported.41,43-45 Two subsequent double-blind randomized placebo-controlled trials showed no survival advantage with high-dose oral vitamin C supplementation as a treatment for cancer.21,24

    • Metabolism of Vitamin C in Health and Disease

      1996, Advances in Pharmacology
    View all citing articles on Scopus
    View full text